LINC01364: A Drug Target / Disease Biomarker (G100505768)

Target Name: LINC01364

NCBI ID: G100505768

LINC01364

Other Name(s): Long intergenic non-protein coding RNA 1364 | long intergenic non-protein coding RNA 1364

LINC01364: A Drug Target / Disease Biomarker

LINC01364 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. Its full name is long non-coding RNA gene LINC01364, and it is classified as a non-coding RNA molecule.

LINC01364 is a key regulator of gene expression in various organisms, and it is involved in the development, maintenance, and regulation of tissues and organs. It is a good candidate drug target, which means that it can be targeted by drugs to treat various diseases.

One of the unique features of LINC01364 is its structure. It is a long non-coding RNA molecule that contains more than 2000 base pairs. It is made up of four exons that are spliced together to form a functional RNA molecule.

The function of LINC01364 is not well understood, but it is believed to play a role in the regulation of cellular processes that are important for the health and development of various organs and tissues. It is expressed in various tissues of the body, including the brain, heart, and kidneys, and it is involved in the development, maintenance, and regulation of these tissues.

LINC01364 is a good candidate drug target because it is involved in the regulation of important cellular processes that are affected by many diseases. For example, LINC01364 is involved in the regulation of cell division, which is important for the growth and development of tissues and organs. It is also involved in the regulation of cell death, which is important for the maintenance of tissue homeostasis and the regulation of various physiological processes that are necessary for life.

In addition to its role in cell regulation, LINC01364 is also involved in the development and maintenance of tissues and organs. It is expressed in various tissues of the body, including the brain, heart, and kidneys, and it is involved in the development, maintenance, and regulation of these tissues. This suggests that LINC01364 may be a useful drug target for diseases that are characterized by the dysfunction of tissues and organs.

The structure of LINC01364 is also unique, as it is a long non-coding RNA molecule that contains more than 2000 base pairs. This makes it a challenging target for drugs, as it is difficult to design small molecules that can specifically interact with its unique structure. However, researchers are still working to develop new drugs that can specifically target LINC01364 and its unique structure.

In conclusion, LINC01364 is a protein that is expressed in various tissues of the body and is involved in the regulation of important cellular processes that are important for the health and development of various organs and tissues. Its unique structure and function make it a good candidate drug target for diseases that are characterized by the dysfunction of tissues and organs. Further research is needed to develop new drugs that can specifically target LINC01364 and its unique structure.

Protein Name: Long Intergenic Non-protein Coding RNA 1364

The "LINC01364 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01364 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets